InnovaHealth Partners

Home → IH Interests → Materna Medical Announces Oral Presentation Comparing Outcomes of Dilator-Experienced vs. Naïve Patients from an At-Home Study

Home → IH Interests → OrthoSpace Announces Publication in Arthroscopy Describing Biomechanical Performance of InSpace Balloon Versus Superior Capsular Reconstruction

Ms. Deland is senior vice president and chief strategy officer at NewYork-Presbyterian, a 4,000-bed academic health care system affiliated with Weill Cornell Medical School and Columbia University. She oversees strategy, service lines and NYP’s venture fund.

Mr. de Panafieu serves on boards of several French companies and advises French and international clients, mainly in finance. He previously advised Credit Agricole Corporate and Investment Bank, led BULL and Lyonnaise des Eaux, and worked for the French government.

Mr. Kean served two terms as governor of New Jersey and president of Drew University. He chaired the Robert Wood Johnson Foundation, Carnegie Corporation of New York and the 9/11 Commission.

Ms. Stricker is an administrative and office manager with over 13 years of experience. Ms. Stricker is responsible for managing the day-to-day operations of the InnovaHealth Partners New York office and also coordinates the firm’s research activities.

InnovaHealth Partners is led by five principals with more than 100 years of combined medical device investing experience. The team has worked together for more than 16 years and has $290 million in assets under management across funds and co-investments.

Monteris Medical develops and markets an FDA-cleared breakthrough robotically-controlled minimally-invasive neurosurgical system.

InnovaHealth Partners’ privacy policy describes how it collects, uses, shares and protects investors’, clients’ and other stakeholders’ non-public personal information in compliance with applicable federal regulations.